Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Core One Labs Inc C.COOL

Alternate Symbol(s):  CLABF

Core One Labs Inc. is a Canada-based life sciences biotechnology research and development company. The Company is focused on bringing psychedelic medicines to market through the development and production of psychedelic compounds, the advancement of psychedelic assisted treatments, and the integration of delivery systems technology. Its subsidiary, Vocan Biotechnologies Inc., has developed and filed for patent protection of a proprietary psilocybin production system using engineered bacteria. It is also the holder of four provisional patents for the development of psychedelic-based pharmaceutical formulations targeting neurological and mental health disorders, under its subsidiary Akome Biotech Ltd., and three provisional patents under its other subsidiary, Awakened Biosciences Inc., for additional synthetic technologies for psilocybin and psilocin production methods. It also holds an interest in four medical clinics, which maintain a combined database of more than 275,000 patients.


CSE:COOL - Post by User

Bullboard Posts
Comment by Jared1111on Aug 29, 2018 11:56pm
120 Views
Post# 28540484

RE:RE:Financials out on SEDAR

RE:RE:Financials out on SEDAR

FastFreddie1 wrote: What was the expectation for revenue?

 

After the $200,000 revenue announcement for June, along with the communication from IR about the transportation license complications, lack of clean biomass, and lab testing backlog, I don't think anyone following the stock was expecting much different than what we got.

Personally, I'm a little suprised it's any higher than the $200,000 initially announced, but I guess they made around $100,000 off of their consulting services.

That being said, Brad's presentation at the Cannacord conference forecasted that LDS would generate a total of $1,512,500 between May and June.

That same chart also predicted that LDS would have a year end revenue of $65,637,500 for 2018. 

While I know I got suckered in by that presentation along with the Equity Guru interview and many conversations with IR and bought more shares as a result, I'm not sure how much of the market took these projections seriously. And anyone who did knew that Brad's presentation was complete nonsense after the company announced June revenues of $200,000.

So, overall, I don't think anyone can really say what investors expectations were at this point.

I know mine were very low.

Bullboard Posts